- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05849818
Virtual Reality Technology For Cognitive Functions Of Children With Down Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Intellectual disability is recognized as one of the most prominent features of DS which is the most common genetic cause of intellectual disability. Cognitive functioning often changes across the lifespan and is moderated by several comorbid factors such as sensory impairments, seizures, autism, sleep disruption, and other medical and psychiatric conditions (Grieco et al., 2015).
There is encouraging evidence supporting the use of non-immersive virtual environments to provide useful learning, rehabilitation, and leisure experiences for people with intellectual disabilities. Therefore, immersive VR applications may also be an effective way to improve motivation and engagement for children with DS in learning settings (Michalski et al., 2022). Therefore, this study aims to investigate the effect of full-immersive VRapeutic software gaming technology on cognitive functions of children with Down syndrome
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Amira Eltohamy, Professor
- Phone Number: 00201001662350
Study Contact Backup
- Name: maya galal, lecturer
- Phone Number: 00201002631238
- Email: maya.galal@pt.cu.edu.eg
Study Locations
-
-
-
Giza, Egypt, 12511
- Recruiting
- Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosed with Down Syndrome Age from 6-10 years Both Genders will be included IQ Ranges from 50-69(mild intellectual disability) they will be able to understand the instructions able to walk independently
Exclusion Criteria:
- Significant Visual or Hearing problems Significant mental or psychological problems that interfere with understanding instructions musculoskeletal problems or fixed deformities in upper or lower limbs Current hospitalization for urgent Medical reasons
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Effect of fully immersive VR + school regular activities on cognitive functions of Down children
Children in this group will practice the same activities as control group in addition to virtual reality session using fully-immersive VRapeutic software gaming technology (Viblio module)for 20 min/3sessions/week for 8 weeks.
|
Other Names:
|
|
No Intervention: Effect of school regular activities on cognitive functions of down children
Children in this group will practice their regular activities of school and daily living (receive no treatment).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of change of cognitive function by using the rehacom device
Time Frame: up to two months
|
Assessing the change of the cognitive function By using the Rehacom Device within two months
|
up to two months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Amira Eltohamy, professor, Cairo University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ayman Kamal
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome
-
Rachel G. Greenberg, MD, MB, MHSEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedHyperactivity in Children With Down Syndrome | Impulsivity in Children With Down SyndromeUnited States
-
Izgi Miray DemirbagRecruitingDown Syndrome (DS)Turkey (Türkiye)
-
Brigham and Women's HospitalNational Institutes of Health (NIH)Not yet recruitingDown Syndrome (DS)United States
-
University of Nevada, Las VegasRecruiting
-
Universidad de BurgosEuropean University Miguel de CervantesRecruiting
-
Aelis FarmaHospital del Mar Research Institute (IMIM)Enrolling by invitation
-
Sohag UniversityActive, not recruitingDown Syndrome | Cervical Spine Instability in Down SyndromeEgypt
-
Alnylam PharmaceuticalsNot yet recruitingDown Syndrome-Associated Alzheimer's Disease (DS-AD)United States
-
Riphah International UniversityCompletedDown S SyndromePakistan
-
Hoffmann-La RocheCompletedHealthy Volunteer, Down SyndromeUnited Kingdom
Clinical Trials on full-immersive VRapeutic software gaming technology
-
Cairo UniversityNot yet recruiting